These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10365597)

  • 1. [The influence of ozone therapy on endothelial damage markers in patients with atherosclerosis of lower extremities].
    Rość D; Ponikowska I; Paczuski R; Włodarczyk K; Zastawna E; Michalski A
    Pol Merkur Lekarski; 1999 Mar; 6(33):135-7. PubMed ID: 10365597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
    Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
    Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Markers of endothelial stimulation in hyperthyroidism].
    Rość D; Drewniak W; Zastawna E; Paczuski R; Graczykowska-Koczorowska A
    Pol Merkur Lekarski; 1999 Feb; 6(32):79-81. PubMed ID: 10337177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does extracorporeal circulation during coronary artery bypass grafting damage vascular endothelium?].
    Kotschy M; Zekanowska E; Rość D; Missima M; Ogorzeja W; Kotschy D
    Pol Merkur Lekarski; 2003 Aug; 15(86):135-9. PubMed ID: 14648977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
    Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease.
    Verrazzo G; Coppola L; Luongo C; Sammartino A; Giunta R; Grassia A; Ragone R; Tirelli A
    Undersea Hyperb Med; 1995 Mar; 22(1):17-22. PubMed ID: 7742706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue plasminogen activator and inhibitor and the severity and extensiveness of vascular lesions in peripheral atherosclerosis of the legs].
    Rość D; Zekanowska E; Hryncewicz W; Cwiklińska-Jurkowska M; Jurkowski P; Kotschy M
    Pol Merkur Lekarski; 1996 Oct; 1(4):235-7. PubMed ID: 9156932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change of vWF, PAl-1 and t-PA in rats with hyperlipemia and its significance].
    Jiang HH; Liu Y; Lin GQ; Li YQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):415-20. PubMed ID: 18544845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
    Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
    Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
    Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study.
    Clausen P; Feldt-Rasmussen B; Jensen G; Jensen JS
    Clin Sci (Lond); 1999 Jul; 97(1):37-43. PubMed ID: 10369792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
    Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
    Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ozone therapy and the activity of selected lysosomal enzymes in blood serum of patients with lower limb ischaemia associated with obliterative atheromatosis.
    Tafil-Klawe M; Woźniak A; Drewa T; Ponikowska I; Drewa J; Drewa G; Włodarczyk K; Olszewska D; Klawe J; Kozłowska R
    Med Sci Monit; 2002 Jul; 8(7):CR520-5. PubMed ID: 12118202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelial parameters in blood plasma of patients suffering from ischaemic heart disease and undergoing surgery with extracorporeal circulation].
    Rość D; Ogorzeja W; Kotschy M; Missima M; Jurkowski P
    Pol Arch Med Wewn; 2004 Nov; 112(5):1297-302. PubMed ID: 15773511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon.
    Marasini B; Cugno M; Bassani C; Stanzani M; Bottasso B; Agostoni A
    Int J Microcirc Clin Exp; 1992 Nov; 11(4):375-82. PubMed ID: 1459797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.